Walking Program in Fatty Liver Children With Phenylketonuria
Condition(s) studied
Investigational drug(s) / intervention(s)
walking free online supervised program: this Group I will include PKU children sufferers (n=20) with non-alcoholic fatty liver that will perform walking program (online supervised free walking that will be applied daily for eight weeks)
Study summary
phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver
Eligibility
Primary outcome measure(s)
- alanine transamianse — it will be assessed after eight weeks
it is a serum liver enzyme
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Cairo University | Dokki | Giza Governorate | Recruiting |
More Cairo University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06718842 on ClinicalTrials.gov ↗ ← All trials in Egypt